Evidence map›Paper›PMID 33081075›Full record

ReviewCancers2020

Chemopreventive Potential of Caryophyllane Sesquiterpenes: An Overview of Preliminary Evidence.

Antonella Di Sotto, Romina Mancinelli, Marco Gullì, Margherita Eufemi, Caterina Loredana Mammola, Gabriela Mazzanti, Silvia Di Giacomo

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Genoprotective Properties ofInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Article
  6. Biological and Medicinal Properties ofInternational journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Modulatory Effect of Cucurbitacin D fromPharmaceuticals (Basel, Switzerland) · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Antonella Di SottoDepartment of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0002-7467-1689
Romina MancinelliDepartment of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0003-2040-0581
Marco GullìDepartment of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy.
Margherita EufemiDepartment of Biochemical Science "A. Rossi Fanelli", Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0001-9153-972X
Caterina Loredana MammolaDepartment of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0001-9221-3932
Gabriela MazzantiDepartment of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy.
Silvia Di GiacomoDepartment of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0003-3049-6644
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemoprevention is referred to as a strategy to inhibit, suppress, or reverse tumor development and progression in healthy people along with high-risk subjects and oncologic patients through using pharmacological or natural substances. Numerous phytochemicals have been widely described in the literature to possess chemopreventive properties, although their clinical usefulness remains to be defined. Among them, caryophyllane sesquiterpenes are natural compounds widely occurring in nature kingdoms, especially in plants, fungi, and marine environments. Several structures, characterized by a common caryophyllane skeleton with further rearrangements, have been identified, but those isolated from plant essential oils, including β-caryophyllene, β-caryophyllene oxide, α-humulene, and isocaryophyllene, have attracted the greatest pharmacological attention. Emerging evidence has outlined a complex polypharmacological profile of caryophyllane sesquiterpenes characterized by blocking, suppressing, chemosensitizing, and cytoprotective properties, which suggests a possible usefulness of these natural substances in cancer chemoprevention for both preventive and adjuvant purposes. In the present review, the scientific knowledge about the chemopreventive properties of caryophyllane sesquiterpenes and the mechanisms involved have been collected and discussed; moreover, possible structure-activity relationships have been highlighted. Although further high-quality studies are required, the promising preclinical findings and the safe pharmacological profile encourage further studies to define a clinical usefulness of caryophyllane sesquiterpenes in primary, secondary, or tertiary chemoprevention.

Indexed as

ABC transportersapoptosisgenoprotectionisocaryophyllenemembrane permeabilityNrf2STAT3α-humuleneβ-caryophylleneβ-caryophyllene oxide

Identifiers

PMID33081075
PMCPMC7603190
OpenAlexW3093277047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.